Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018
Clinical Pharmacology & Therapeutics · 2023-10 · 114 (4) · 836-844
DOI: 10.1002/cpt.2981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 11.07.2023. Verfasst von Martha M Werler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Prescription Drugs. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, EPA, NCBDD CDC HHS.
Abstract (Originalsprache)
The objective of this analysis was to describe patterns of prescription medication use during pregnancy, including secular trends, with consideration of indication, and distributions of use within demographic subgroups. We conducted a descriptive secondary analysis using data from 9,755 women whose infants served as controls in two large United States case–control studies from 1997–2011 and 2014–2018. After excluding vitamin, herbal, mineral, vaccine, i.v. fluid, and topical products and over‐the‐counter medications, the proportion of women that reported taking at least one prescription medication in the first trimester increased over the study years, from 37% to 50% of women. The corresponding proportions increased with increasing maternal age and years of education, were highest for non‐Hispanic White women (47%) and lowest for Hispanic women (24%). The most common indication for first trimester use of a medication was infection (12–15%). Increases were observed across the years for medications used for indications related to nausea/vomiting, depression/anxiety, infertility, thyroid disease, diabetes, and epilepsy. The largest relative increase in use among women was observed for medications to treat nausea/vomiting, which increased from 3.8% in the earliest years of the study (1997–2001) to 14.8% in 2014–2018, driven in large part by ondansetron use. Prescription medication use in the first trimester of pregnancy is common and increasing. Many medical conditions require treatments among pregnant women, often involving pharmacotherapy, which necessitates consideration of the risk and safety profiles for both mother and fetus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
- Slone Epidemiology Center at Boston University School of Medicine, Boston, Massachusetts, USA.
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Birth Defects Registry, New York State Department of Health; Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, New York, USA.
- Department of Epidemiology, Harvard TH Chan School of Public Health, Harvard University, Cambridge, Massachusetts, USA.
ORCID-Profile: Martha M Werler, Marilyn L Browne
Förderung
- HSRD VA
- EPA
- NCBDD CDC HHS
- Intramural CDC HHS
Zitieren
APA
Werler, M. M., Kerr, S. M., Ailes, E. C., Reefhuis, J., Gilboa, S. M., Browne, M. L., Kelley, K. E., Hernandez-Diaz, S., Smith-Webb, R. S., Garcia, M. H., Mitchell, A. A., & National Birth Defects Prevention Study and Birth Defects Study To Evaluate Pregnancy exposureS (2023). Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018. Clinical Pharmacology & Therapeutics, 114(4), 836-844. https://doi.org/10.1002/cpt.2981
Vancouver
Werler MM, Kerr SM, Ailes EC, Reefhuis J, Gilboa SM, Browne ML, et al. Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018. Clinical Pharmacology & Therapeutics. 2023;114(4):836-844. doi:10.1002/cpt.2981
BibTeX
@article{Werler2023,
author = {Werler, Martha M and Kerr, Stephen M and Ailes, Elizabeth C and Reefhuis, Jennita and Gilboa, Suzanne M and Browne, Marilyn L and Kelley, Katherine E and Hernandez-Diaz, Sonia and Smith-Webb, Rashida S and Garcia, Michelle Huezo and Mitchell, Allen A and National Birth Defects Prevention Study and Birth Defects Study To Evaluate Pregnancy exposureS, National Birth Defects Prevention Study and Birth Defects Study To Evaluate Pregnancy exposureS},
title = {Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018},
journal = {Clinical Pharmacology & Therapeutics},
year = {2023},
volume = {114},
number = {4},
pages = {836--844},
doi = {10.1002/cpt.2981}
}
EUVIMED